ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,448,448, issued on Oct. 21, was assigned to Incyte Corp. (Wilmington, Del.) and MacroGenics Inc. (Rockville, Md.).
"Anti-PD-1 antibodies and uses thereof" was invented by Mark Cornfeld (Philadelphia), Naimish Bharat Pandya (Rockville, Md.), Jon Marc Wigginton (Rockville, Md.), Ross La Motte-Mohs (Rockville, Md.) and Bradley James Sumrow (Rockville, Md.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of treatment of cancer with antibodies and antibody fragments that bind to PD-1 are disclosed."
The patent was filed on June 18, 2019, under Application No. 16/444,691.
*For further information, including images, charts and tables, please visit: htt...